Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-18 4:28 pm Sale | 2022-12-31 | 13G | Synaptogenix, Inc. SNPX | HAYWOOD GEORGE WEAVER | 0 0.000% | -19,400 (Position Closed) | Filing History |
| 2022-02-10 2:46 pm Sale | 2021-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI | HAYWOOD GEORGE WEAVER | 4,500 0.200% | -97,123 (-95.57%) | Filing History |
| 2022-02-10 2:45 pm Purchase | 2021-12-31 | 13G | Synaptogenix, Inc. SNPX | HAYWOOD GEORGE WEAVER | 19,400 7.000% | 19,400 (New Position) | Filing History |
| 2021-10-27 09:47 am Purchase | 2021-10-19 | 13G | Petros Pharmaceuticals, Inc. PTPI | HAYWOOD GEORGE WEAVER | 101,623 7.600% | 101,623 (New Position) | Filing History |
| 2021-02-11 6:16 pm Purchase | 2020-12-31 | 13G | Synaptogenix, Inc. SNPX | HAYWOOD GEORGE WEAVER | 14,434 9.700% | 14,434 (New Position) | Filing History |
| 2020-02-13 11:32 am Sale | 2019-12-31 | 13G | Acasti Pharma Inc. ACST | HAYWOOD GEORGE WEAVER | 37,538 2.100% | -116,564 (-75.64%) | Filing History |
| 2020-02-12 11:11 am Sale | 2019-12-31 | 13G | NextTrip, Inc. NTRP | HAYWOOD GEORGE WEAVER | 5,126 7.800% | -624 (-10.85%) | Filing History |